Baxter International Inc

자세한 내용은 Baxter International Inc 회사

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

회사 정보

종목 코드 BAX

회사 이름Baxter International Inc

상장일May 15, 1961

설립일1931

CEO- -

직원 수38000

유형Ordinary Share

회계 연도 종료May 15

주소One Baxter Parkway

도시DEERFIELD

증권 거래소NYSE Consolidated

국가United States of America

우편 번호60015

전화12249482000

웹사이트https://www.baxter.com/

종목 코드 BAX

상장일May 15, 1961

설립일1931

회사 임원

이름

이름/직위

직위

주식 보유

변동

Ms. Heather Knight

Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies

177.32K

+11.79%

Dr. Jeanne K. Mason, Ph.D.

Chief Human Resources Officer, Executive Vice President

141.67K

+7.47%

Mr. Alok Sonig

Executive Vice President, Group President - Pharmaceuticals

130.30K

+15.20%

Mr. David S. Rosenbloom

Executive Vice President, General Counsel

101.60K

-14.01%

Dr. Stephen N. (Steve) Oesterle, M.D.

Independent Director

35.70K

+25.18%

Ms. Catherine R. (Cathy) Smith

Independent Director

30.23K

+31.17%

Ms. Patricia B. (Patty) Morrison

Independent Director

22.94K

+45.58%

Mr. Stephen H. (Steve) Rusckowski

Independent Director

16.45K

+77.49%

Mr. Jeffrey A. (Jay) Craig

Independent Director

10.65K

+206.88%

Ms. Nancy M. Schlichting

Lead Independent Director

7.97K

+912.71%

이름

이름/직위

직위

주식 보유

변동

Ms. Heather Knight

Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies

177.32K

+11.79%

Dr. Jeanne K. Mason, Ph.D.

Chief Human Resources Officer, Executive Vice President

141.67K

+7.47%

Mr. Alok Sonig

Executive Vice President, Group President - Pharmaceuticals

130.30K

+15.20%

Mr. David S. Rosenbloom

Executive Vice President, General Counsel

101.60K

-14.01%

Dr. Stephen N. (Steve) Oesterle, M.D.

Independent Director

35.70K

+25.18%

Ms. Catherine R. (Cathy) Smith

Independent Director

30.23K

+31.17%

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

사업별USD

이름

수익

비율

Infusion Therapies and Technologies

994.00M

37.87%

Care and Connectivity Solutions

427.00M

16.27%

Injectables and Anesthesia

335.00M

12.76%

Front Line Care

277.00M

10.55%

Advanced Surgery

268.00M

10.21%

Other

324.00M

12.34%

지역별USD

이름

수익

비율

United States

1.49B

56.76%

International

1.14B

43.24%

사업별

지역별

사업별USD

이름

수익

비율

Infusion Therapies and Technologies

994.00M

37.87%

Care and Connectivity Solutions

427.00M

16.27%

Injectables and Anesthesia

335.00M

12.76%

Front Line Care

277.00M

10.55%

Advanced Surgery

268.00M

10.21%

Other

324.00M

12.34%

주식 보유 통계

마지막 업데이트: Thu, May 1

주주

주주 유형

주주

비율

The Vanguard Group, Inc.

11.85%

Dodge & Cox

10.03%

Pzena Investment Management, LLC

7.67%

BlackRock Institutional Trust Company, N.A.

5.90%

State Street Global Advisors (US)

4.24%

Other

60.31%

주주

비율

The Vanguard Group, Inc.

11.85%

Dodge & Cox

10.03%

Pzena Investment Management, LLC

7.67%

BlackRock Institutional Trust Company, N.A.

5.90%

State Street Global Advisors (US)

4.24%

Other

60.31%

주주 유형

주주

비율

Investment Advisor

44.80%

Investment Advisor/Hedge Fund

43.39%

Hedge Fund

2.89%

Research Firm

2.31%

Pension Fund

1.97%

Insurance Company

1.46%

Bank and Trust

1.29%

Sovereign Wealth Fund

0.97%

Individual Investor

0.37%

Other

0.56%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

1873

510.14M

99.41%

-21.30M

2025Q1

1934

508.09M

99.01%

-37.41M

2024Q4

1984

501.11M

97.98%

-41.68M

2024Q3

2005

485.40M

95.14%

-42.32M

2024Q2

2042

472.72M

92.77%

-47.98M

2024Q1

2091

469.13M

92.11%

-57.76M

2023Q4

2137

471.69M

92.98%

-44.04M

2023Q3

2123

465.39M

91.91%

-35.52M

2023Q2

2140

458.55M

90.66%

-30.65M

2023Q1

2123

459.27M

90.86%

-22.24M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

The Vanguard Group, Inc.

60.82M

11.85%

+290.58K

+0.48%

Mar 31, 2025

Dodge & Cox

51.46M

10.03%

-122.48K

-0.24%

Mar 31, 2025

Pzena Investment Management, LLC

36.77M

7.17%

+3.13M

+9.32%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

30.27M

5.9%

+743.24K

+2.52%

Mar 31, 2025

State Street Global Advisors (US)

21.77M

4.24%

-21.20K

-0.10%

Mar 31, 2025

T. Rowe Price Associates, Inc.

19.57M

3.81%

+4.32M

+28.32%

Mar 31, 2025

BlackRock Financial Management, Inc.

17.99M

3.51%

+419.98K

+2.39%

Mar 31, 2025

Geode Capital Management, L.L.C.

12.56M

2.45%

+109.37K

+0.88%

Mar 31, 2025

Harris Associates L.P.

9.00M

1.75%

+540.70K

+6.39%

Mar 31, 2025

Columbia Threadneedle Investments (US)

7.42M

1.45%

+133.41K

+1.83%

Mar 31, 2025

관련 ETF

마지막 업데이트: 35 minutes ago

이름

비율

Cullen Enhanced Equity Income ETF

2.77%

iShares Large Cap Value Active ETF

2.32%

First Trust Indxx Medical Devices ETF

1.96%

iShares U.S. Medical Devices ETF

1.77%

SPDR S&P Health Care Equipment ETF

1.76%

North Shore Equity Rotation ETF

1.68%

Invesco S&P 500 Equal Weight Health Care ETF

1.6%

VanEck Morningstar SMID Moat ETF

1.2%

Humankind US Stock ETF

0.96%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

0.81%

Cullen Enhanced Equity Income ETF

비율2.77%

iShares Large Cap Value Active ETF

비율2.32%

First Trust Indxx Medical Devices ETF

비율1.96%

iShares U.S. Medical Devices ETF

비율1.77%

SPDR S&P Health Care Equipment ETF

비율1.76%

North Shore Equity Rotation ETF

비율1.68%

Invesco S&P 500 Equal Weight Health Care ETF

비율1.6%

VanEck Morningstar SMID Moat ETF

비율1.2%

Humankind US Stock ETF

비율0.96%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

비율0.81%

주식 배당금

지난 5년 동안 총 2.75B USD의 배당금이 분배되었습니다.

날짜

배당금

기준일

지급일

배당락일

Feb 11, 2025

BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option

Feb 28, 2025

Apr 01, 2025

Feb 28, 2025

Nov 11, 2024

BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option

Nov 29, 2024

Jan 02, 2025

Nov 29, 2024

Jul 16, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option

Aug 30, 2024

Oct 01, 2024

Aug 30, 2024

May 07, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option

May 31, 2024

Jul 01, 2024

May 31, 2024

Feb 12, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option

Mar 01, 2024

Apr 01, 2024

Feb 29, 2024

Nov 14, 2023

BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option

Dec 01, 2023

Jan 02, 2024

Nov 30, 2023

Jul 18, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option

Sep 01, 2023

Oct 02, 2023

Aug 31, 2023

May 01, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 03, 2023 going ex on Jun 01, 2023

Jun 02, 2023

Jul 03, 2023

Jun 01, 2023

Feb 14, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 03, 2023 going ex on Feb 23, 2023 with reinvestment option

Feb 24, 2023

Apr 03, 2023

Feb 23, 2023

Nov 15, 2022

BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 03, 2023 going ex on Dec 01, 2022

Dec 02, 2022

Jan 03, 2023

Dec 01, 2022

주식 분할

날짜

유형

비율

데이터 없음

날짜

유형

비율

데이터 없음

21.960USD

Baxter International Inc

21.960

개요

회사

금융